The momentum generated by these developments underscores our commitment to delivering life-changing therapies ... received the Israel Prize for the invention and development of Rebif®, a multiple ...

Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a ...

The company released the topline data from both studies in December 2024. Also Read: Merck Injects $1 Billion To Expand Vaccine Production In US Merck plans to begin submitting applications for ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

Merck announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12 billion U.S. investment ...

DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new $1 billion vaccine manufacturing facility in North Durham. The plant will manufacture the HPV vaccines Gardasil and ...

Merck KGaA said it appointed two new members to the executive board for the life science and healthcare business sectors, along with a newly-created chief people officer role. The German ...

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...